Skip to content

Clinical study of Qihuang needle therapy in the treatment of mixed cervical spondylosis based on infrared thermal imaging technology

Clinical study of Qihuang needle therapy in the treatment of mixed cervical spondylosis based on infrared thermal imaging technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000040
Enrollment
Unknown
Registered
2025-01-07
Start date
2023-09-01
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mixed cervical spondylosis

Interventions

1:Qihuang needl
2:ordinary acupuncture therapy

Sponsors

Guangzhou University of Chinese Medicine Shenzhen Hospital (Futian))
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria for mixed cervical spondylosis (CCS mixed CSR) in the Expert Consensus on Classification Diagnosis and Non-surgical Treatment of Cervical Spondylosis and the Diagnostic Efficacy Criteria for Orthopedic Syndromes of Traditional Chinese Medicine; 2) Be between the ages of 20-65;3) Patients who have signed the informed consent form and can cooperate to complete the treatment.

Exclusion criteria

Exclusion criteria: 1) Other subtypes of cervical spondylosis; 2) Traumatic cervical spondylosis cervical fractures and dislocations; 3) Rheumatism rheumatoid arthritis tumors tuberculosis severe osteoporosis congenital malformations and other diseases; 4) Individuals with bleeding tendencies and coagulation disorders; 5) Patients with serious cardiovascular and cerebrovascular diseases diabetes high fever local skin damage and severe skin peptide disease; 6) Patients with acute infectious diseases systemic infection or infectious disease at the treatment site: patients with damaged neck skin and severe skin disease; 7) Pregnant or lactating women and mentally ill patients who are unable to live; 8) Those who have not been treated according to regulations and cannot determine the efficacy.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale/Score; VAS;20 point Tianzhong Jingjiu Cervical Symptom Scale data;Neck Disability Index; NDI;

Secondary

MeasureTime frame
the root mean square (RMS) of upper trapezius;average body surface temperature of upper trapezius;

Countries

China

Contacts

Public ContactHuang Bingjing

Sanming Second Hospital

1634113665@qq.com13055557689

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026